Ocular surface neovascularization and its resulting pathological changes significantly alter
corneal refraction and obstruct light path to the retina, and hence is a major cause of vision …

Corneal neovascularization (CoNV) is a sight-threatening condition affecting an estimated
1.4 million people per year, and the incidence is expected to rise. It is a complication of …

Abstract Rationale: Corneal neovascularization (CoNV) is a severe complication of various
types of corneal diseases, that leads to permanent visual impairment. Current treatments for …

Purpose To assess the effectiveness of topical and subconjunctival bevacizumab in
suppressing vascularization in graft and host bed after high-risk corneal transplantation …

Corneal neovascularization (CoNV) leads to visual impairment, affecting over 1.4 million
people in the United States per year. It is caused by a variety of pathologies, such as …

Purpose To report on the preliminary outcomes of mitomycin C (MMC) intravascular
chemoembolization (MICE) for corneal neovascularization (NV). Methods This is a …

AIM To investigate the effectiveness and safety of subconjunctival injection of conbercept in
the treatment of corneal neovascularization (CNV). METHODS The data on 10 consecutively …

Corneal neovascularization can impair vision and result in a poor quality of life. The
pathogenesis involves a complex interplay of angiogenic factors, notably vascular …

The management of corneal NV has evolved to include several standalone and combination
medical and surgical options. Additionally, improvements in quantifying corneal NV and …

A healthy cornea is a nonvascularized, transparent tissue. It is nourished by diffusion
through the tear film, aqueous fluid and neurotrophins supplied by the corneal innervation …